Position in EXEL
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$257,957
+$54,616 QoQ
Shares Held
4,741
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#545
of 751 holders
Holding Since
Sep 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Founders Financial Alliance, LLC holds $760,151 across 2 Biotechnology names. EXEL ranks #2 (33.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,011 | $502,194 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
4,741 | $257,957 |
All Filings in EXEL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $257,957 | 4,741 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $203,341 | 4,741 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $207,798 | 4,741 | Shares | Sole | 2026-02-12 | |
| 2025-06-30 | $208,983 | 4,741 | Shares | Sole | 2025-08-12 | |
| 2020-09-30 | $9,046 | 370 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||